Registration
KING & SPALDING LLP for SUMITOMO PHARMA AMERICA (FORMERLY SUNOVION PHARMACEUTICALS, INC.)
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Price controls and issues related to implementation of the Independent Payment Advisory Board (IPAB) and Center for Medicare and Medicaid Innovation (CMI)
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK MORRISEY New | Deputy Staff Director, House E&C Cmte; Staff, Rep. Frisa |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| DAINIPPON SUMITOMO PHARMA CO., LTD. | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.